Mosaic Biosciences is a protein and antibody discovery firm that helps partners identify and develop next-generation protein therapeutics from concept through preclinical development. Its teams offer end-to-end services including antibody discovery and optimization, protein production and characterization, protein engineering, assay development, formulation and developability studies, and pharmacology and bioanalytical support. Mosaic works with biopharmaceutical companies, startups, and university-affiliated funds to accelerate discovery programs and reduce timelines and costs. The company announced an $11.4 million growth financing to support commercial growth and expand its discovery capabilities and services. Proceeds will be used to expand lab facility infrastructure, develop new technologies and capabilities, augment the business development team, and grow the scientific staff. The financing is intended to help Mosaic scale its service offerings and meet evolving partner needs in protein and antibody therapeutic discovery.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2022